Alnylam Pharmaceuticals, Inc. v. Moderna, Inc.

 
APPEAL NO.
23-2357
OP. BELOW
DCT
OPINION
TBD
SUBJECT
Patent
AUTHOR
TBD

Issue(s) Presented

“The principal issue presented is whether the district court erred in limiting the terms ‘branched alkyl’ and ‘branched C10-C20 alkyl’ through lexicography to require one carbon atom in the group to be bound to at least three other carbon atoms, where the claims are not so limited, and the specification and prosecution history specify numerous examples of branching where a carbon atom is bound to two or three other carbon atoms.”

Posts About this Case